Assessment of Potential Interactions Between Cocaine and RPR 102681 - 1

The purpose of this study is to assess Potential Interactions Between iv Cocaine and RPR 102681

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cocaine-Related Disorders Chemically-Induced Disorders Mental Disorders Substance-Related Disorders

Age range

18 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

Uniformed Services University of Health Science

Bethesda, Maryland, 20814 4799, United States

About this study

Phase I, Double-Blind, Placebo-Controlled Dose Escalating Assessment of Potential Interactions Between Intravenous Cocaine and RPR 102681

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Includes but is not limited to:

Non-treatment seekers
DSM-IV criteria for cocaine abuse or dependence
Ability to verbalize understanding of consent form and provide written informed consent and verbalize willingness to complete study procedures; be able to comply with protocol requirements

Exclusion criteria

Please contact site for more information.

Treatment and study plan

Cocaine-Related Disorders

Drug

Primary outcomes

Hemodynamic response to cocaine and subjective response to cocaine

Time frame: 3x / 30 days

Sponsors and collaborators

Lead sponsor

National Institute on Drug Abuse (NIDA)

Nih

Registry information

Official study title

Potential Interactions Between IV Cocaine and RPR 102681

Important dates

Study start: 2003
Primary completion: 2005
Study completion: 2005
First posted: Aug 25, 2003
Registry last updated: Jan 12, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed